{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T13:57:22Z","timestamp":1774360642579,"version":"3.50.1"},"reference-count":37,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2015,6,24]],"date-time":"2015-06-24T00:00:00Z","timestamp":1435104000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0125214","type":"journal-article","created":{"date-parts":[[2015,6,24]],"date-time":"2015-06-24T18:28:38Z","timestamp":1435170518000},"page":"e0125214","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":23,"title":["Modeling the Health and Economic Burden of Hepatitis C Virus in Switzerland"],"prefix":"10.1371","volume":"10","author":[{"given":"Beat","family":"M\u00fcllhaupt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Bruggmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Bihl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Blach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Lavanchy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Homie","family":"Razavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Semela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Negro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,6,24]]},"reference":[{"key":"ref1","first-page":"1","article-title":"State of the art of new vaccine research and development","volume":"01","year":"2006"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1038\/474S18a","article-title":"Perspective: test and treat this silent killer","volume":"474","author":"BR Edlin","year":"2011","journal-title":"Nature"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1469-0691.2010.03432.x","article-title":"Evolving epidemiology of hepatitis C virus","volume":"17","author":"D Lavanchy","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.2105\/AJPH.90.10.1562","article-title":"Estimating future hepatitis C morbidity, mortality, and costs in the United States","volume":"90","author":"JB Wong","year":"2000","journal-title":"Am J Public Health"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"271","DOI":"10.7326\/0003-4819-156-4-201202210-00004","article-title":"The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007","volume":"156","author":"KN Ly","year":"2012","journal-title":"Ann Intern Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/hep.510310332","article-title":"The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States","volume":"31","author":"GL Armstrong","year":"2000","journal-title":"Hepatology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1053\/gast.2002.33023","article-title":"Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C","volume":"122","author":"T Poynard","year":"2002","journal-title":"Gastroenterology"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1093\/cid\/cit234","article-title":"A risk for hepatocellular carcinoma persists long-term after sustained virologic response in patients with hepatitis C-associated liver cirrhosis","volume":"57","author":"S Aleman","year":"2013","journal-title":"Clin Infect Dis"},{"key":"ref9","first-page":"0","article-title":"Hepatitis B and C in Switzerland-healthcare provider initiated testing for chronic hepatitis B and C infection","volume":"143","author":"R Fretz","year":"2013","journal-title":"Swiss Med Wkly"},{"issue":"Suppl 2","key":"ref10","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1478-3231.2011.02539.x","article-title":"A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel","volume":"31","author":"M Cornberg","year":"2011","journal-title":"Liver Int"},{"issue":"Suppl 1","key":"ref11","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/jvh.12248","article-title":"The present and future disease burden of hepatitis C virus (HCV) infection with today&apos;s treatment paradigm","volume":"21","author":"H Razavi","year":"2014","journal-title":"J Viral Hepat"},{"issue":"Suppl 1","key":"ref12","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/jvh.12247","article-title":"Historical epidemiology of hepatitis C virus (HCV) in selected countries","volume":"21","author":"P Bruggmann","year":"2014","journal-title":"J Viral Hepat"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00042737-200201000-00006","article-title":"Simulation of hepatitis C based on a mandatory reporting system","volume":"14","author":"M Sagmeister","year":"2002","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref14","unstructured":"Swiss Federal Office of Public Health (2013) Number of hepatitis C cases reported in Switzerland between 1988 and 2012 by year of birth (mandatory notification of laboratory confirmed cases): FOPH\/ID\/EPI\/RIC."},{"key":"ref15","unstructured":"The Swiss Hepatitis C Cohort Study (2014) Study Population; Some salient features. [cites April 15 2014] Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.swisshcv.ch\/study-population.htm\" xlink:type=\"simple\">http:\/\/www.swisshcv.ch\/study-population.htm<\/ext-link>."},{"key":"ref16","doi-asserted-by":"crossref","first-page":"705","DOI":"10.7326\/0003-4819-144-10-200605160-00004","article-title":"The prevalence of hepatitis C virus infection in the United States, 1999 through 2002","volume":"144","author":"GL Armstrong","year":"2006","journal-title":"Ann Intern Med"},{"key":"ref17","unstructured":"United Nations Department of Economic and Social Affairs Population Division (2011) World population prospects: The 2010 revision. Population database. [cited:Feb 1 2013]. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/esa.un.org\/unpd\/wpp\/index.htm\" xlink:type=\"simple\">http:\/\/esa.un.org\/unpd\/wpp\/index.htm<\/ext-link>."},{"key":"ref18","article-title":"Number of acute cases of hepatitis C in Switzerland by reporting year: FOPH\/ID\/EPI\/RIC","year":"2013","journal-title":"Number of acute cases of hepatitis C in Switzerland by reporting year: FOPH\/ID\/EPI\/RIC"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/hep.26141","article-title":"Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence","volume":"57","author":"K Mohd Hanafiah","year":"2013","journal-title":"Hepatology"},{"key":"ref20","article-title":"Permanent foreign resident population by nationality by country and Canton, 1990\u20132010","year":"2011","journal-title":"Permanent foreign resident population by nationality by country and Canton, 1990\u20132010"},{"key":"ref21","unstructured":"University of California B, Max Planck Institute for Demographic Research (2013) Human Mortality Database. Jun 14 2013 [cited:Feb 1 2013]. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.mortality.org\" xlink:type=\"simple\">www.mortality.org<\/ext-link>."},{"key":"ref22","unstructured":"Swiss Federal Statistics Office (2013) Fatalities by institutional divisions, gender, nationality, marital status and age group, 1971\u20132010. STAT-TAB: The interactive statistical database. [cited:Jun 17 2013] Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.pxweb.bfs.admin.ch\/Dialog\/statfile.asp?lang=1\" xlink:type=\"simple\">http:\/\/www.pxweb.bfs.admin.ch\/Dialog\/statfile.asp?lang=1<\/ext-link>."},{"key":"ref23","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2471\/BLT.12.108282","article-title":"Mortality among people who inject drugs: a systematic review and meta-analysis","volume":"91","author":"BM Mathers","year":"2013","journal-title":"Bull World Health Organ"},{"issue":"Suppl 3","key":"ref24","first-page":"iii56","article-title":"Using cohort studies to estimate mortality among injecting drug users that is not attributable to AIDS","volume":"82","author":"L Degenhardt","year":"2006","journal-title":"Sex Transm Infect"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/pubmed\/fdp067","article-title":"Assessing IDU prevalence and health consequences (HCV, overdose and drug-related mortality) in a primary care trust: implications for public health action","volume":"31","author":"M Hickman","year":"2009","journal-title":"J Public Health (Oxf)"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1465-3362.2009.00167.x","article-title":"Combined effects of law enforcement and substitution treatment on heroin mortality","volume":"29","author":"C Nordt","year":"2010","journal-title":"Drug Alcohol Rev"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/ije\/dym096","article-title":"Cohort profile: The Swiss hepatitis C cohort study (SCCS)","volume":"36","author":"L Prasad","year":"2007","journal-title":"Int J Epidemiol"},{"key":"ref28","doi-asserted-by":"crossref","DOI":"10.2807\/ese.13.21.18881-en","article-title":"Trends in drug consumption and risk of transmission of HIV and hepatitis C virus among injecting drug users in Switzerland, 1993\u20132006","volume":"13","author":"F Dubois-Arber","year":"2008","journal-title":"Euro Surveill"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1002\/hep.26218","article-title":"Chronic hepatitis C virus (HCV) disease burden and cost in the United States","volume":"57","author":"H Razavi","year":"2013","journal-title":"Hepatology"},{"key":"ref30","unstructured":"IMS Health (2013) IMS Health MIDAS Data. IMS Health. Jan 1 2013 Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.imshealth.com\/portal\/site\/ims\/menuitem.edb2b81823f67dab41d84b903208c22a\/?vgnextoid=4475e3de7e390310VgnVCM1000007f8c2ca2RCRD\" xlink:type=\"simple\">http:\/\/www.imshealth.com\/portal\/site\/ims\/menuitem.edb2b81823f67dab41d84b903208c22a\/?vgnextoid=4475e3de7e390310VgnVCM1000007f8c2ca2RCRD<\/ext-link>."},{"key":"ref31","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1007\/s10620-006-9669-0","article-title":"High deferral rates and poorer treatment outcomes for HCV patients with psychiatric and substance use comorbidities","volume":"52","author":"DM Evon","year":"2007","journal-title":"Dig Dis Sci"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/j.1525-1497.2005.0161.x","article-title":"Barriers to the treatment of hepatitis C. Patient, provider, and system factors","volume":"20","author":"JA Morrill","year":"2005","journal-title":"J Gen Intern Med"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1056\/NEJMoa1009370","article-title":"Outcomes of treatment for hepatitis C virus infection by primary care providers","volume":"364","author":"S Arora","year":"2011","journal-title":"N Engl J Med"},{"key":"ref34","first-page":"1","article-title":"Task Shifting: Global Recommendations and Guidelines","year":"2008","journal-title":"Task Shifting: Global Recommendations and Guidelines"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/heapol\/czs058","article-title":"The effectiveness and cost implications of task-shifting in the delivery of antiretroviral therapy to HIV-infected patients: a systematic review","volume":"28","author":"ND Mdege","year":"2013","journal-title":"Health Policy Plan"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/hep.26590","article-title":"Expanding access to hepatitis C virus care: a call to deconstruct individualized therapy","volume":"59","author":"A Aronsohn","year":"2014","journal-title":"Hepatology"},{"key":"ref37","first-page":"1","article-title":"Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945\u20131965","volume":"61","author":"BD Smith","year":"2012","journal-title":"MMWR Recomm Rep"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0125214","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T17:37:01Z","timestamp":1566927421000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0125214"}},"subtitle":[],"editor":[{"given":"Chen-Hua","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,6,24]]},"references-count":37,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2015,6,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0125214","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,24]]}}}